Both in Pharmaceuticals
Aktis Oncology vs Mannkind
Over the past year AKTS returned −12.1% and MNKD returned −42.9%; their daily moves had a correlation of 0.23.
AKTS −12.1% MNKD −42.9%Growth of $1, one year, split-adjusted
| Metric | AKTS | MNKD |
|---|---|---|
| Price | $19.69 | $3.34 |
| Market cap | $1.10B | $1.07B |
| Today | +1.76% | −0.30% |
| 1 month | −23.6% | −15.4% |
| 6 months | +19.0% | +40.9% |
| Year to date | — | −41.1% |
| 1 year | — | −39.6% |
| Revenue growth (YoY) | — | +42.9% |
| Gross margin | 100.0% | 73.0% |
| Net margin | −713.5% | −17.4% |
| P/E (TTM) | — | — |
| Price / sales | — | 2.7× |
| Net cash | $517.3M | -$373.9M |
| Dividend yield | — | — |
| Volatility (60d) | 52.5% | 49.6% |
| Short % of float | 14.3% | 10.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).